These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 2954264)
1. Influence of acetylsalicylic acid (1.0 g/day) on platelet survival time, beta-thromboglobulin and platelet factor 4 in patients with peripheral arterial occlusive disease. Minar E; Ehringer H Thromb Res; 1987 Mar; 45(6):791-802. PubMed ID: 2954264 [TBL] [Abstract][Full Text] [Related]
2. Lack of influence of low-dose acetylsalicylic acid (100 mg daily) on platelet survival time, beta-thromboglobulin and platelet factor 4 in patients with peripheral arterial occlusive disease. Minar E; Ehringer H; Jung M; Koppensteiner R; Stümpflen A Thromb Res; 1988 Nov; 52(3):219-26. PubMed ID: 2973666 [TBL] [Abstract][Full Text] [Related]
3. Reproducibility of platelet survival time measurements in patients with peripheral arterial occlusive disease. Minar E; Ehringer H Thromb Res; 1987 Oct; 48(1):73-9. PubMed ID: 2962335 [TBL] [Abstract][Full Text] [Related]
4. Lack of elevation of beta-thromboglobulin and platelet factor 4 in plasma during exercise in patients with chronic peripheral arterial occlusive disease. Minar E; Ehringer H; Schöfl R Klin Wochenschr; 1987 May; 65(9):419-23. PubMed ID: 2955158 [TBL] [Abstract][Full Text] [Related]
5. [Lack of effect of low dose acetylsalicylic acid (100 mg/die) on thrombocyte survival and beta-thromboglobulin (beta-TG) and platelet factor 4 (PF 4) in patients with peripheral arterial occlusive disease]. Minar E; Ehringer H; Jung M; Koppensteiner R; Stümpflen A; Ahmadi R Vasa Suppl; 1989; 27():244-6. PubMed ID: 2533741 [No Abstract] [Full Text] [Related]
6. Platelet deposition at angioplasty sites and platelet survival time after PTA in iliac and femoral arteries: investigations with indium-111-oxine labelled platelets in patients with ASA (1.0 g/day)-therapy. Minar E; Ehringer H; Ahmadi R; Dudczak R; Porenta G Thromb Haemost; 1987 Aug; 58(2):718-23. PubMed ID: 2960029 [TBL] [Abstract][Full Text] [Related]
7. No effect of acetylsalicylic acid on B-thromboglobulin and platelet factor 4 plasma levels in patients with transient ischaemic attacks. Carrieri P; Orefice G; Indaco A Stroke; 1986; 17(6):1153-5. PubMed ID: 2949396 [TBL] [Abstract][Full Text] [Related]
8. Platelet activation in angina at rest. Evidence by paired measurement of plasma beta-thromboglobulin and platelet factor 4. De Caterina R; Gazzetti P; Mazzone A; Marzilli M; L'Abbate A Eur Heart J; 1988 Aug; 9(8):913-22. PubMed ID: 2972544 [TBL] [Abstract][Full Text] [Related]
9. Flow cytometric assessment of platelet function in patients with peripheral arterial occlusive disease. Galt SW; McDaniel MD; Ault KA; Mitchell J; Cronenwett JL J Vasc Surg; 1991 Dec; 14(6):747-55; discussion 755-6. PubMed ID: 1720468 [TBL] [Abstract][Full Text] [Related]
10. Plasma beta-thromboglobulin and platelet factor 4 in patients with chronic renal failure and effect of hemodialysis. Endo Y; Mamiya S; Satoh M; Takahashi K; Harada T Tohoku J Exp Med; 1981 Dec; 135(4):349-58. PubMed ID: 6175048 [TBL] [Abstract][Full Text] [Related]
11. Platelet behavior in patients with TIA: responsiveness to small doses of aspirin. D'Andrea G; Toldo M; Cananzi A; Cortelazzo S; Ferro-Milone F Eur Neurol; 1985; 24(6):426-32. PubMed ID: 2933258 [TBL] [Abstract][Full Text] [Related]
12. Platelet damage caused by the centrifugal pump: in vitro evaluation by measuring the release of alpha-granule packing proteins. Kawahito K; Mohara J; Misawa Y; Fuse K Artif Organs; 1997 Oct; 21(10):1105-9. PubMed ID: 9335369 [TBL] [Abstract][Full Text] [Related]
13. Plasma levels of beta-thromboglobulin and platelet factor 4 in relation to the venous platelet concentration. Kutti J; Safai-Kutti S; Zaroulis CG; Good RA Acta Haematol; 1980; 64(1):1-5. PubMed ID: 6158243 [TBL] [Abstract][Full Text] [Related]
14. Platelet factor 4 and beta thromboglobulin in Moya-Moya disease. Albala MM; Levine PH Am J Pediatr Hematol Oncol; 1984; 6(1):96-9. PubMed ID: 6201080 [TBL] [Abstract][Full Text] [Related]
15. Platelet factor 4 (PF4) and heparin-released platelet factor 4 (HR-PF4) in patients with cardiovascular disorders. Cella G; Colby SI; Taylor AD; McCracken L; Parisi AF; Sasahara AA Thromb Res; 1983 Mar; 29(5):499-509. PubMed ID: 6222505 [TBL] [Abstract][Full Text] [Related]
16. Relevance of platelet factor four (PF4) plasma levels in multiple sclerosis. Cananzi AR; Ferro-Milone F; Grigoletto F; Toldo M; Meneghini F; Bortolon F; D'Andrea G Acta Neurol Scand; 1987 Aug; 76(2):79-85. PubMed ID: 2960124 [TBL] [Abstract][Full Text] [Related]
17. A study of beta-thromboglobulin and platelet factor-4 plasma levels in steady state sickle cell patients. Adamides S; Konstantopoulos K; Toumbis M; Douratsos D; Travlou A; Kasfiki A Blut; 1990 Oct; 61(4):245-7. PubMed ID: 2145991 [TBL] [Abstract][Full Text] [Related]
18. Effect of cellulose acetate 0.2 micron filter on platelet specific proteins plasma levels. Stevanato F; Paolini R; Fabris F; Casonato A; Cella G Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(3):377-81. PubMed ID: 1703106 [TBL] [Abstract][Full Text] [Related]